Evidence map›Paper›PMID 37686860›Full record

ArticleNutrients2023

A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy.

Fusheng Xu, Zhiming Yu, Yaru Liu, Ting Du, Leilei Yu, Fengwei Tian, Wei Chen, Qixiao Zhai

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. A novel exopolysaccharide fromGut microbes · 2026
    Article
  4. Review
  5. Combined Effect ofFoods (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Effects and mechanism ofWorld journal of gastroenterology · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Gut microbes reports · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Gut Microbiota-Targeted Intervention of Hyperlipidemia UsingPharmaceuticals (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Fusheng XuState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.
Zhiming YuWuxi People's Hospital Afliated to Nanjing Medical University, Wuxi 214023, China.
Yaru LiuState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.
Ting DuState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.
Leilei YuState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.ORCID 0000-0002-3191-3123
Fengwei TianState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.
Wei ChenState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.
Qixiao ZhaiState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi 214122, China.ORCID 0000-0002-0605-2675
Jiangnan University · CNWuxi People's Hospital · CN

Funding

Qixiao Zhai 32021005Qixiao Zhai 32122067Qixiao Zhai JUSRP622013Wei Chen BK20200084
6 · The paper itself

Abstract

Patients with post-cholecystectomy (PC) often experience adverse gastrointestinal conditions, such as PC syndrome, colorectal cancer (CRC), and non-alcoholic fatty liver disease (NAFLD), that accumulate over time. An epidemiological survey further revealed that the risk of cholecystectomy is associated with high-fat and high-cholesterol (HFHC) dietary intake. Mounting evidence suggests that cholecystectomy is associated with disrupted gut microbial homeostasis and dysregulated bile acids (BAs) metabolism. However, the effect of an HFHC diet on gastrointestinal complications after cholecystectomy has not been elucidated. Here, we aimed to investigate the effect of an HFHC diet after cholecystectomy on the gut microbiota-BA metabolic axis and elucidate the association between this alteration and the development of intestinal inflammation. In this study, a mice cholecystectomy model was established, and the levels of IL-Iβ, TNF-α, and IL-6 in the colon were increased in mice fed an HFHC diet for 6 weeks. Analysis of fecal BA metabolism showed that an HFHC diet after cholecystectomy altered the rhythm of the BA metabolism by upregulating liver CPY7A1, CYP8B1, and BSEP and ileal ASBT mRNA expression levels, resulting in increased fecal BA levels. In addition, feeding an HFHC diet after cholecystectomy caused a significant dysbiosis of the gut microbiota, which was characterized by the enrichment of the metabolic microbiota involved in BAs; the abundance of pro-inflammatory gut microbiota and related pro-inflammatory metabolite levels was also significantly higher. In contrast, the abundance of major short-chain fatty acid (SCFA)-producing bacteria significantly decreased. Overall, our study suggests that an HFHC diet after cholecystectomy promotes intestinal inflammation by exacerbating the gut microbiome and BA metabolism dysbiosis in cholecystectomy. Our study also provides useful insights into the maintenance of intestinal health after cholecystectomy through dietary or probiotic intervention strategies.

Indexed as

Gastrointestinal MicrobiomeHypercholesterolemiaAnimalsBile Acids and SaltsCholecystectomyCholesterolDisease Models, AnimalDysbiosisInflammationMiceBile Acids and SaltsCholesterolbile acidscholesteroldietgut microbiotainflammationpost-cholecystectomy

Identifiers

PMID37686860
PMCPMC10489946
OpenAlexW4386380159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.